List of Tables
Table 1. Global Olopatadine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Olopatadine Market Value by Chemical Structure, (US$ Million) & (2024 VS 2031)
Table 3. Global Olopatadine Market Value by Population, (US$ Million) & (2024 VS 2031)
Table 4. Global Olopatadine Market Value by Optical Isomers, (US$ Million) & (2024 VS 2031)
Table 5. Global Olopatadine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 6. Global Olopatadine Market Competitive Situation by Manufacturers in 2024
Table 7. Global Olopatadine Sales (K Units) of Key Manufacturers (2020-2025)
Table 8. Global Olopatadine Sales Market Share by Manufacturers (2020-2025)
Table 9. Global Olopatadine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 10. Global Olopatadine Revenue Share by Manufacturers (2020-2025)
Table 11. Global Market Olopatadine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 12. Global Key Players of Olopatadine, Industry Ranking, 2022 VS 2023 VS 2024
Table 13. Global Key Manufacturers of Olopatadine, Manufacturing Sites & Headquarters
Table 14. Global Key Manufacturers of Olopatadine, Product Type & Application
Table 15. Global Key Manufacturers of Olopatadine, Date of Enter into This Industry
Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Olopatadine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Olopatadine as of 2024)
Table 18. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 19. Global Olopatadine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 20. Global Olopatadine Sales by Region (2020-2025) & (K Units)
Table 21. Global Olopatadine Sales Market Share by Region (2020-2025)
Table 22. Global Olopatadine Sales by Region (2026-2031) & (K Units)
Table 23. Global Olopatadine Sales Market Share by Region (2026-2031)
Table 24. Global Olopatadine Revenue by Region (2020-2025) & (US$ Million)
Table 25. Global Olopatadine Revenue Market Share by Region (2020-2025)
Table 26. Global Olopatadine Revenue by Region (2026-2031) & (US$ Million)
Table 27. Global Olopatadine Revenue Market Share by Region (2026-2031)
Table 28. North America Olopatadine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. North America Olopatadine Sales by Country (2020-2025) & (K Units)
Table 30. North America Olopatadine Sales by Country (2026-2031) & (K Units)
Table 31. North America Olopatadine Revenue by Country (2020-2025) & (US$ Million)
Table 32. North America Olopatadine Revenue by Country (2026-2031) & (US$ Million)
Table 33. Europe Olopatadine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 34. Europe Olopatadine Sales by Country (2020-2025) & (K Units)
Table 35. Europe Olopatadine Sales by Country (2026-2031) & (K Units)
Table 36. Europe Olopatadine Revenue by Country (2020-2025) & (US$ Million)
Table 37. Europe Olopatadine Revenue by Country (2026-2031) & (US$ Million)
Table 38. Asia Pacific Olopatadine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 39. Asia Pacific Olopatadine Sales by Region (2020-2025) & (K Units)
Table 40. Asia Pacific Olopatadine Sales by Region (2026-2031) & (K Units)
Table 41. Asia Pacific Olopatadine Revenue by Region (2020-2025) & (US$ Million)
Table 42. Asia Pacific Olopatadine Revenue by Region (2026-2031) & (US$ Million)
Table 43. Latin America Olopatadine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Latin America Olopatadine Sales by Country (2020-2025) & (K Units)
Table 45. Latin America Olopatadine Sales by Country (2026-2031) & (K Units)
Table 46. Latin America Olopatadine Revenue by Country (2020-2025) & (US$ Million)
Table 47. Latin America Olopatadine Revenue by Country (2026-2031) & (US$ Million)
Table 48. Middle East and Africa Olopatadine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Middle East and Africa Olopatadine Sales by Country (2020-2025) & (K Units)
Table 50. Middle East and Africa Olopatadine Sales by Country (2026-2031) & (K Units)
Table 51. Middle East and Africa Olopatadine Revenue by Country (2020-2025) & (US$ Million)
Table 52. Middle East and Africa Olopatadine Revenue by Country (2026-2031) & (US$ Million)
Table 53. Global Olopatadine Sales (K Units) by Type (2020-2025)
Table 54. Global Olopatadine Sales (K Units) by Type (2026-2031)
Table 55. Global Olopatadine Sales Market Share by Type (2020-2025)
Table 56. Global Olopatadine Sales Market Share by Type (2026-2031)
Table 57. Global Olopatadine Revenue (US$ Million) by Type (2020-2025)
Table 58. Global Olopatadine Revenue (US$ Million) by Type (2026-2031)
Table 59. Global Olopatadine Revenue Market Share by Type (2020-2025)
Table 60. Global Olopatadine Revenue Market Share by Type (2026-2031)
Table 61. Global Olopatadine Price (US$/Unit) by Type (2020-2025)
Table 62. Global Olopatadine Price (US$/Unit) by Type (2026-2031)
Table 63. Global Olopatadine Sales (K Units) by Application (2020-2025)
Table 64. Global Olopatadine Sales (K Units) by Application (2026-2031)
Table 65. Global Olopatadine Sales Market Share by Application (2020-2025)
Table 66. Global Olopatadine Sales Market Share by Application (2026-2031)
Table 67. Global Olopatadine Revenue (US$ Million) by Application (2020-2025)
Table 68. Global Olopatadine Revenue (US$ Million) by Application (2026-2031)
Table 69. Global Olopatadine Revenue Market Share by Application (2020-2025)
Table 70. Global Olopatadine Revenue Market Share by Application (2026-2031)
Table 71. Global Olopatadine Price (US$/Unit) by Application (2020-2025)
Table 72. Global Olopatadine Price (US$/Unit) by Application (2026-2031)
Table 73. Alcon Inc. Company Information
Table 74. Alcon Inc. Description and Business Overview
Table 75. Alcon Inc. Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Alcon Inc. Olopatadine Product
Table 77. Alcon Inc. Recent Developments/Updates
Table 78. Novartis AG Company Information
Table 79. Novartis AG Description and Business Overview
Table 80. Novartis AG Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Novartis AG Olopatadine Product
Table 82. Novartis AG Recent Developments/Updates
Table 83. Bausch & Lomb Incorporated Company Information
Table 84. Bausch & Lomb Incorporated Description and Business Overview
Table 85. Bausch & Lomb Incorporated Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Bausch & Lomb Incorporated Olopatadine Product
Table 87. Bausch & Lomb Incorporated Recent Developments/Updates
Table 88. Bausch Health Companies Inc. Company Information
Table 89. Bausch Health Companies Inc. Description and Business Overview
Table 90. Bausch Health Companies Inc. Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Bausch Health Companies Inc. Olopatadine Product
Table 92. Bausch Health Companies Inc. Recent Developments/Updates
Table 93. Santen Pharmaceutical Co., Ltd. Company Information
Table 94. Santen Pharmaceutical Co., Ltd. Description and Business Overview
Table 95. Santen Pharmaceutical Co., Ltd. Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Santen Pharmaceutical Co., Ltd. Olopatadine Product
Table 97. Santen Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 98. Kyowa Kirin Co., Ltd. (Kyowa Hakko Kogyo) Company Information
Table 99. Kyowa Kirin Co., Ltd. (Kyowa Hakko Kogyo) Description and Business Overview
Table 100. Kyowa Kirin Co., Ltd. (Kyowa Hakko Kogyo) Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Kyowa Kirin Co., Ltd. (Kyowa Hakko Kogyo) Olopatadine Product
Table 102. Kyowa Kirin Co., Ltd. (Kyowa Hakko Kogyo) Recent Developments/Updates
Table 103. Teva Pharmaceutical Industries Ltd. Company Information
Table 104. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 105. Teva Pharmaceutical Industries Ltd. Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Teva Pharmaceutical Industries Ltd. Olopatadine Product
Table 107. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 108. Mylan N.V. (Viatris Inc.) Company Information
Table 109. Mylan N.V. (Viatris Inc.) Description and Business Overview
Table 110. Mylan N.V. (Viatris Inc.) Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Mylan N.V. (Viatris Inc.) Olopatadine Product
Table 112. Mylan N.V. (Viatris Inc.) Recent Developments/Updates
Table 113. Hikma Pharmaceuticals PLC Company Information
Table 114. Hikma Pharmaceuticals PLC Description and Business Overview
Table 115. Hikma Pharmaceuticals PLC Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Hikma Pharmaceuticals PLC Olopatadine Product
Table 117. Hikma Pharmaceuticals PLC Recent Developments/Updates
Table 118. Dr. Reddy’s Laboratories Company Information
Table 119. Dr. Reddy’s Laboratories Description and Business Overview
Table 120. Dr. Reddy’s Laboratories Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Dr. Reddy’s Laboratories Olopatadine Product
Table 122. Dr. Reddy’s Laboratories Recent Developments/Updates
Table 123. Sun Pharmaceutical Industries Ltd. Company Information
Table 124. Sun Pharmaceutical Industries Ltd. Description and Business Overview
Table 125. Sun Pharmaceutical Industries Ltd. Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 126. Sun Pharmaceutical Industries Ltd. Olopatadine Product
Table 127. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 128. Lupin Limited Company Information
Table 129. Lupin Limited Description and Business Overview
Table 130. Lupin Limited Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 131. Lupin Limited Olopatadine Product
Table 132. Lupin Limited Recent Developments/Updates
Table 133. Alembic Pharmaceuticals Limited Company Information
Table 134. Alembic Pharmaceuticals Limited Description and Business Overview
Table 135. Alembic Pharmaceuticals Limited Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 136. Alembic Pharmaceuticals Limited Olopatadine Product
Table 137. Alembic Pharmaceuticals Limited Recent Developments/Updates
Table 138. Glenmark Company Information
Table 139. Glenmark Description and Business Overview
Table 140. Glenmark Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 141. Glenmark Olopatadine Product
Table 142. Glenmark Recent Developments/Updates
Table 143. Aurobindo Pharma Limited Company Information
Table 144. Aurobindo Pharma Limited Description and Business Overview
Table 145. Aurobindo Pharma Limited Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 146. Aurobindo Pharma Limited Olopatadine Product
Table 147. Aurobindo Pharma Limited Recent Developments/Updates
Table 148. Cipla Limited Company Information
Table 149. Cipla Limited Description and Business Overview
Table 150. Cipla Limited Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 151. Cipla Limited Olopatadine Product
Table 152. Cipla Limited Recent Developments/Updates
Table 153. Zydus Cadila Company Information
Table 154. Zydus Cadila Description and Business Overview
Table 155. Zydus Cadila Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 156. Zydus Cadila Olopatadine Product
Table 157. Zydus Cadila Recent Developments/Updates
Table 158. Apotex Inc. Company Information
Table 159. Apotex Inc. Description and Business Overview
Table 160. Apotex Inc. Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 161. Apotex Inc. Olopatadine Product
Table 162. Apotex Inc. Recent Developments/Updates
Table 163. Fresenius Kabi AG Company Information
Table 164. Fresenius Kabi AG Description and Business Overview
Table 165. Fresenius Kabi AG Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 166. Fresenius Kabi AG Olopatadine Product
Table 167. Fresenius Kabi AG Recent Developments/Updates
Table 168. Ajanta Pharma Limited Company Information
Table 169. Ajanta Pharma Limited Description and Business Overview
Table 170. Ajanta Pharma Limited Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 171. Ajanta Pharma Limited Olopatadine Product
Table 172. Ajanta Pharma Limited Recent Developments/Updates
Table 173. Gland Pharma Limited Company Information
Table 174. Gland Pharma Limited Description and Business Overview
Table 175. Gland Pharma Limited Olopatadine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 176. Gland Pharma Limited Olopatadine Product
Table 177. Gland Pharma Limited Recent Developments/Updates
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. Olopatadine Distributors List
Table 181. Olopatadine Customers List
Table 182. Olopatadine Market Trends
Table 183. Olopatadine Market Drivers
Table 184. Olopatadine Market Challenges
Table 185. Olopatadine Market Restraints
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
Table 189. Authors List of This Report
List of Figures
Figure 1. Product Picture of Olopatadine
Figure 2. Global Olopatadine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Olopatadine Market Share by Type: 2024 & 2031
Figure 4. Oral Preparations Product Picture
Figure 5. Topical Preparations Product Picture
Figure 6. Ophthalmic Preparations Product Picture
Figure 7. Global Olopatadine Market Value by Chemical Structure, (US$ Million) & (2020-2031)
Figure 8. Global Olopatadine Market Share by Chemical Structure: 2024 VS 2031
Figure 9. Olopatadine Hydrochloride Product Picture
Figure 10. Olopatadine Fumarate Product Picture
Figure 11. Free Base Form Product Picture
Figure 12. Global Olopatadine Market Value by Population, (US$ Million) & (2020-2031)
Figure 13. Global Olopatadine Market Share by Population: 2024 VS 2031
Figure 14. Adults Product Picture
Figure 15. Children (2-11 Years Old) Product Picture
Figure 16. Seniors (over 65 Years Old) Product Picture
Figure 17. Global Olopatadine Market Value by Optical Isomers, (US$ Million) & (2020-2031)
Figure 18. Global Olopatadine Market Share by Optical Isomers: 2024 VS 2031
Figure 19. Racemate (DL-Type) Product Picture
Figure 20. Single Isomer (R-Type) Product Picture
Figure 21. Global Olopatadine Market Value by Application (2020-2031) & (US$ Million)
Figure 22. Global Olopatadine Market Share by Application: 2024 & 2031
Figure 23. Hospitals
Figure 24. Clinics
Figure 25. Pharmacies
Figure 26. Others
Figure 27. Global Olopatadine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 28. Global Olopatadine Market Size (2020-2031) & (US$ Million)
Figure 29. Global Olopatadine Sales (2020-2031) & (K Units)
Figure 30. Global Olopatadine Average Price (US$/Unit) & (2020-2031)
Figure 31. Olopatadine Report Years Considered
Figure 32. Olopatadine Sales Share by Manufacturers in 2024
Figure 33. Global Olopatadine Revenue Share by Manufacturers in 2024
Figure 34. Global 5 and 10 Largest Olopatadine Players: Market Share by Revenue in Olopatadine in 2024
Figure 35. Olopatadine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 36. Global Olopatadine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 37. North America Olopatadine Sales Market Share by Country (2020-2031)
Figure 38. North America Olopatadine Revenue Market Share by Country (2020-2031)
Figure 39. United States Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Canada Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Europe Olopatadine Sales Market Share by Country (2020-2031)
Figure 42. Europe Olopatadine Revenue Market Share by Country (2020-2031)
Figure 43. Germany Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. France Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. U.K. Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Italy Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Russia Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Asia Pacific Olopatadine Sales Market Share by Region (2020-2031)
Figure 49. Asia Pacific Olopatadine Revenue Market Share by Region (2020-2031)
Figure 50. China Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Japan Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. South Korea Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. India Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Australia Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. China Taiwan Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Southeast Asia Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Latin America Olopatadine Sales Market Share by Country (2020-2031)
Figure 58. Latin America Olopatadine Revenue Market Share by Country (2020-2031)
Figure 59. Mexico Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Brazil Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 61. Argentina Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 62. Colombia Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 63. Middle East and Africa Olopatadine Sales Market Share by Country (2020-2031)
Figure 64. Middle East and Africa Olopatadine Revenue Market Share by Country (2020-2031)
Figure 65. Turkey Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 66. Saudi Arabia Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 67. UAE Olopatadine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 68. Global Sales Market Share of Olopatadine by Type (2020-2031)
Figure 69. Global Revenue Market Share of Olopatadine by Type (2020-2031)
Figure 70. Global Olopatadine Price (US$/Unit) by Type (2020-2031)
Figure 71. Global Sales Market Share of Olopatadine by Application (2020-2031)
Figure 72. Global Revenue Market Share of Olopatadine by Application (2020-2031)
Figure 73. Global Olopatadine Price (US$/Unit) by Application (2020-2031)
Figure 74. Olopatadine Value Chain
Figure 75. Channels of Distribution (Direct Vs Distribution)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
